A method and composition for treating blepharitis or blepharoconjunctivitis comprises topical administration of a nitroimidazole compound, e.g. metronidazole in a suitable carrier directly to affected ocular tissues. The carrier can be an artificial tear solution or an ointment or water soluble gel base.